Intraperitoneal co-administration of thymosin α-1 ameliorates streptozotocin-induced pancreatic lesions and diabetes in C57BL/6 mice

International Journal of Molecular Medicine

Volumn 23, Issue 5, 2009, Pages 597-602

  Qiu, Longxin ^a,b   Zhang, Cuilin ^a   Zhang, Jun ^a   Liang, Jiaxin ^a   Liu, Jun ^a   Ji, Cishu ^a   Yang, James Y ^a  

^a XIAMEN UNIVERSITY   (China)

^b LONGYAN UNIVERSITY   (China)

Author keywords

Insulin; Oxidative stress; Pancreas; Streptozotocin; Thymosin 1; Type I diabetes mellitus

Indexed keywords

CATALASE; FUCHSINE; GLUCOSE; GLUTATHIONE; INSULIN; MALONALDEHYDE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THYMOSIN ALPHA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; IN VIVO STUDY; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PANCREAS INJURY; PANCREAS ISLET BETA CELL; PANCREATITIS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAPERITONEAL; INSULIN; MALE; MICE; MICE, INBRED C57BL; PANCREAS; PANCREATIC DISEASES; STREPTOZOCIN; THYMOSIN;

EID: 67649422186     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000169     Document Type: Article

References (34)

1. Goldstein AL and Badamchian M: Thymosins: chemistry and biological properties in health and disease. Expert Opin Biol Ther 4: 559-573, 2004.
2. Hannappel E and Huff T: The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function. Vitam Horm 66: 257-296, 2003.
3. Segade F and Gomez-Marquez J: Prothymosin alpha. Int J Biochem Cell Biol 31: 1243-1248, 1999.
4. Goldstein AL, Hannappel E and Kleinman HK: Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 11: 421-429, 2005.
5. Ancell CD, Phipps J and Young L: Thymosin alpha-1. Am J Health Syst Pharm 58: 879-885, 2001.
6. Billich A: Thymosin alpha1. SciClone Pharmaceuticals. Curr Opin Investig Drugs 3: 698-707, 2002.
7. Garaci E, Favalli C, Pica F, Sinibaldi VP, Palamara AT, Matteucci C, Pierimarchi P, Serafino A, Mastino A, Bistoni F, Romani L and Rasi G: Thymosin alpha 1: from bench to bedside. Ann NY Acad Sci 1112: 225-234, 2007.
8. Salvin SB and Tanner EP: Resistance and susceptibility to infection in inbred murine strains. III. Effect of thymosin on cellular immune responses of alloxan diabetic mice. Clin Exp Immunol 55: 133-139, 1984.
9. Okimoto T, Kinoshita Y, Hato F, Toyokawa T, Kimura S and Kinoshita H: Effects of thymosin on soybean lectin responsiveness of thymic small lymphocyte subsets from streptozotocin-induced diabetic rats. Cell Mol Biol 34: 465-472, 1988.
10. Winter WE, Robbins V, Elder M, Barrett D, Martin N and Maclaren NK: Thymosin and the spontaneously diabetic BB rat. Autoimmunity 1: 115-123, 1988.
11. Strausser HR: Use of thymosin as an anti-diabetes and antihypertensive disease agent. US Patent #4,444,757, 1984.
12. Tabata T, Kinoshita Y, Fujii S, Hato F, Toyokawa T, Kimura S and Morii H: Protection by thymosin fraction 5 from streptozotocin-induced diabetes in mice. Cell Mol Biol 35: 121-127, 1989.
13. Mizina TI: Hypoglycemic effect of thymosine in an animal experiment. Vopr Med Khim 35: 80-82, 1989.
14. Yao W, Zhu Q, Yuan Y, Qiao M, Zhang Y and Zhai Z: Thymosin alpha 1 improves severe acute pancreatitis in rats via regulation of peripheral T cell number and cytokine serum level. J Gastroenterol Hepatol 22: 1866-1871, 2007.
15. Sinha AK: Colorimetric assay of catalase. Anal Biochem 47: 389-394, 1972.
16. Jennings BM: Aldehyde-fuchsin staining applied to sections for demonstrating pituitary and pancreatic beta cells. J Histochem Cytochem 13: 328-333, 1965.
17. Low TL, Thurman GB, McAdoo M, McClure J, Rossio JL, Naylor PH and Goldstein AL: The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus. J Biol Chem 254: 981-986, 1979.
18. Romani L, Bistoni F, Montagnoli C, Gaziano R, Bozza S, Bonifazi P, Zelante T, Moretti S, Rasi G, Garaci E and Puccetti P: Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance. Ann NY Acad Sci 1112: 326-338, 2007.
19. Sztein MB and Serrate SA: Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes. Int J Immunopharmacol 11: 789-800, 1989.
20. Wang SH, Chen G and Zhang K: Effects of thymosin and insulin on suppressor T cell in type 1 diabetes. Diabetes Res 19: 21-29, 1992.
21. Malinda KM, Sidhu GS, Banaudha KK, Gaddipati JP, Maheshwari RK, Goldstein AL and Kleinman HK: Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing. J Immunol 160: 1001-1006, 1998.
22. Koutrafouri V, Leondiadis L, Avgoustakis K, Livaniou E, Czarnecki J, Ithakissios DS and Evangelatos GP: Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model. Biochim Biophys Acta 1568: 60-66, 2001.
23. Kakkar R, Kalra J, Mantha SV and Prasad K: Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 151: 113-119, 1995.
24. West IC: Radicals and oxidative stress in diabetes. Diabet Med 17: 171-180, 2000.
25. Wolff SP: Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 49: 642-652, 1993.
26. Kajimoto Y and Kaneto H: Role of oxidative stress in pancreatic beta-cell dysfunction. Ann NY Acad Sci 1011: 168-176, 2004.
27. Peschke E, Ebelt H, Bromme HJ and Peschke D: 'Classical' and 'new' diabetogens - comparison of their effects on isolated rat pancreatic islets in vitro. Cell Mol Life Sci 57: 158-164, 2000.
28. Evans JS, Gerritsen GC, Mann KM and Owen SP: Antitumor and hyperglycemic activity of streptozotocin (NSC-37917) and its cofactor, U-15,774. Cancer Chemother Rep 48: 1-6, 1965.
29. Gonzalez E, Jawerbaum A, Sinner D, Pustovrh C, White V, Capobianco E, Xaus C, Peralta C and Rosello-Catafau J: Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway. Nitric Oxide 6: 214-220, 2002.
30. Li L, Zhou JH, Xing ST and Lau BH: Thymus-neuroendocrine-liver pathway. Med Hypotheses 41: 470-472, 1993.
31. Lau BH, Li L and Yoon P: Thymic peptide protects vascular endothelial cells from hydrogen peroxide-induced oxidant injury. Life Sci 52: 1787-1796, 1993.
32. Ademoglu E, Gokkusu C and Oz B: Thymosin alpha-1: evidence for an antiatherogenic effect. Ann Nutr Metab 42: 283-289, 1998.
33. Armutcu F, Coskun O, Gurel A, Kanter M, Can M, Ucar F and Unalacak M: Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Clin Biochem 38: 540-547, 2005.
34. Gokkusu C, Ademoglu E, Turkoglu UM, Oz H and Oz F: Thymosin alpha 1 protects liver and aorta from oxidative damage in atherosclerotic rabbits. Life Sci 59: 1059-1067, 1996.